Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Developing Measures To Access Compliance with Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for the Prevention of Healthcare Associated Methicillin Resistant Staphylococcus Aureus and Related Multidrug Resistant Organisms, Potential Extramural Project (PEP) 2008-R-20, 20678 [E8-8107]

Download as PDF 20678 Federal Register / Vol. 73, No. 74 / Wednesday, April 16, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Developing Measures To Access Compliance with Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for the Prevention of Healthcare Associated Methicillin Resistant Staphylococcus Aureus and Related Multidrug Resistant Organisms, Potential Extramural Project (PEP) 2008–R–20 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Barriers to Implementing Standing Orders for Adult Immunization in the Office Setting, Potential Extramural Project (PEP) 2008–R–18 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: jlentini on PROD1PC65 with NOTICES Time and Date: 1 p.m.–2:30 p.m., May 19, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Developing Measures to Access Compliance with CDC/ HICPAC Recommendations for the Prevention of Healthcare Associated Methicillin Resistant Staphylococcus Aureus and Related Multidrug Resistant Organisms, PEP 2008–R– 20.’’ For Further Information Contact: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8107 Filed 4–15–08; 8:45 am] BILLING CODE 4163–18–P In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–2 p.m., May 15, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Barriers to Implementing Standing Orders for Adult Immunization in the Office Setting, PEP 2008–R–18.’’ For Further Information Contact: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8108 Filed 4–15–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Expansion of the National Mesothelioma Virtual Registry and Tissue Bank, Request for Application (RFA) OH08–002 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease VerDate Aug<31>2005 19:08 Apr 15, 2008 Jkt 214001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–2 p.m., May 5, 2008 (Closed). Place: CDC, 2400 Century Center Parkway, 4th Floor, Atlanta, GA 30345. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Expansion of the National Mesothelioma Virtual Registry and Tissue Bank, RFA OH08–002.’’ For Further Information Contact: Charles N. Rafferty, Ph.D., Assistant Director for Review and Policy, Office of Extramural Programs, CDC, 1600 Clifton Road, NE., Mailstop E74, Atlanta, GA 30333, Telephone (404) 498–2530. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8123 Filed 4–15–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Feasibility Study of Using Cancer Registries and Other Data Sources To Track Measure of Care in Colorectal and Breast Cancer, Potential Extramural Project (PEP) 2008–R–08 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–3 p.m., May 28, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Feasibility Study of Using Cancer Registries and other Data Sources to E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 73, Number 74 (Wednesday, April 16, 2008)]
[Notices]
[Page 20678]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8107]



[[Page 20678]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Developing Measures To Access Compliance with 
Centers for Disease Control and Prevention (CDC)/Healthcare Infection 
Control Practices Advisory Committee (HICPAC) Recommendations for the 
Prevention of Healthcare Associated Methicillin Resistant 
Staphylococcus Aureus and Related Multidrug Resistant Organisms, 
Potential Extramural Project (PEP) 2008-R-20

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1 p.m.-2:30 p.m., May 19, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Developing Measures to Access 
Compliance with CDC/ HICPAC Recommendations for the Prevention of 
Healthcare Associated Methicillin Resistant Staphylococcus Aureus 
and Related Multidrug Resistant Organisms, PEP 2008-R-20.''
    For Further Information Contact: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-8107 Filed 4-15-08; 8:45 am]
BILLING CODE 4163-18-P